Cvs Pharmacy #00929 Durable Medical Equipment & Medical Supplies Location: 272 East Central Street Route 140, Franklin, Massachusetts 02038 Phone: (508) 528-0794 |
Cvs Pharmacy # 01873 Durable Medical Equipment & Medical Supplies Location: 435 West Central Street, Franklin, Massachusetts 02038 Phone: (508) 520-0253 |
Stop & Shop Pharmacy #472 Medicare Supplier Location: 40 Franklin Village Dr, Franklin, Massachusetts 02038 Phone: (508) 520-4106 |
Osco Pharmacy #3581 Durable Medical Equipment & Medical Supplies Location: 255 E Central St, Franklin, Massachusetts 02038 Phone: (508) 520-7017 |
Walgreens #13005 Durable Medical Equipment & Medical Supplies Location: 160 E Central St, Franklin, Massachusetts 02038 Phone: (508) 541-1436 |
Hudson Home Health Care, Inc. Durable Medical Equipment & Medical Supplies Location: 101 Constitution Blvd, Franklin, Massachusetts 02038 Phone: (508) 623-2500 |
Cambridge Eye Medicare Supplier Location: 230 Franklin Village Dr, Franklin, Massachusetts 02038 Phone: (508) 528-3911 |
News Archive
Cell Therapeutics, today announced that the Office of New Drugs of the U.S. Food and Drug Administration after carefully reviewing the materials CTI submitted in support of its appeal, the reviews of the New Drug Application for pixantrone prepared by the FDA staff, the transcript of the March 22, 2010 Oncology Drugs Advisory Committee meeting and consulting with the Center for Drug Evaluation and Research's Deputy Director of Clinical Science and the Office of Biostatistics, concluded that accelerated approval of pixantrone NDA 022481 may not necessarily be out of reach based on a single controlled clinical trial, provided two key matters can be satisfactorily resolved.
Scientists have identified where a four-stranded version of DNA exists within the genome of human cells, and suggest that it may hold a key to developing new, targeted therapies for cancer.
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, announced that Risk Metrics Group (RMG), an advisor to institutional investors on corporate governance and risk management issues, issued recommendations to its institutional clients regarding proposals to be considered at Safeguard's annual meeting of shareholders.
The link between obesity and high-risk pregnancies caused by preeclampsia and diabetes will be the focus of a $2.4 million National Institutes of Health research grant received by Sean Blackwell, M.D., associate professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at The University of Texas Medical School at Houston.
› Verified 9 days ago